"Xianwei Vision" has completed an over 100 million yuan Series A financing.

36Kr has learned that recently, Xianwei Vision Technology (Nanjing) Co., Ltd. has completed an over 100 million yuan Series A financing round. This round of financing is led by Lilly Asia Ventures, with KaiFeng Ventures as a co-investor. The old shareholders Nanjing Innovation Investment Group and Dingxin Capital continue to increase their investments. HaoYue Capital serves as the exclusive financial advisor for this round of financing. The funds raised will be used to promote the clinical trial and registration declaration of the "Femtosecond Laser Corneal Refractive Surgery Device", and accelerate the product's listing and commercialization process.